HeartSciences Stock Rated “Strong Buy” by Analysts
Each $3.50 Unit Includes One Convertible Preferred Share and a Warrant to Purchase an Additional Common Share at $5.00
500% potential
Analyst Confidence Signals 6X Near-Term Upside Potential
ECG technology
Special Terms Only Available Through This Offering
shares
Detecting Heart Disease Sooner With AI
HeartSciences is preparing for commercialization in the U.S. and abroad, with the first commercial customer signed and early commercial use of its device taking place in several European centers.